PMC:7103696 / 488-641 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":19,"end":33},"obj":"Body_part"},{"id":"T2","span":{"begin":59,"end":66},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":" early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":134,"end":135},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":59,"end":66},"obj":"Chemical"},{"id":"T4","span":{"begin":130,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_33382"}],"text":" early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":38,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:D006495"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China t"}